Yahoo Web Search

Search results

    • Tempus AI shares soar in Nasdaq debut

      Tempus AI shares soar in Nasdaq debut

      Proactive Investors· 14 hours ago

      SoftBank Group-backed Tempus AI shares surged over 15% after itsNasdaq debut Friday, valuing the AI-driven genetic testing company at around $6.6...

    • Initial public offerings scheduled to debut next week

      Houston Chronicle· 7 hours ago

      The following is a list of initial public offerings planned for the coming week. Actuate Therapeutics - Fort Worth, Texas, 5.6 million shares, priced at $8-$10, managed by Titan Partners Newbridge ...